Preserved phosphorylation of RET receptor protein in spinal motor neurons of patients with amyotrophic lateral sclerosis: An immunohistochemical study by a phosphorylation-specific antibody at tyrosine 1062

Brain Research

Volumn 912, Issue 1, 2001, Pages 89-94

  Yamamoto, Masahiko ^a   Li, Mei ^a   Mitsuma, Norimasa ^a   Ito, Shinji ^a   Kato, Masashi ^a   Takahashi, Masahide ^a   Sobue, Gen ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Amyotrophic lateral sclerosis; Phosphorylation; Ret; Spinal cord motor neuron; Tyrosine 1062

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN RET; TYROSINE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; AUTOPHOSPHORYLATION; CELL SURVIVAL; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SPINAL CORD MOTONEURON;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANTERIOR HORN CELLS; ANTIBODY SPECIFICITY; DROSOPHILA PROTEINS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR RECEPTORS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION;

EID: 0035979832     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(01)02542-2     Document Type: Article

References (29)

1. A mutation at tyrosine 1062 in MEN2A-Ret and MEN2B-Ret impairs their transforming activity and association with Shc adaptor proteins
2. Neurotrophic factors and their receptors
3. Peripheral target regulation of the development and survival of spinal sensory and motor neurons in the chick embryo
4. Mutations in the extracellular domain cause RET loss of function by a dominant negative mechanism
5. Tyrosine 1062 of RET-MEN2A mediates activation of Akt (Protein kinase B) and mitogen-activated protein kinase pathway leading to PC12 cell survival
6. Activation of phosphatidylinositol 3-kinase, but not extracellular-regulated kinases, is necessary to mediate brain-derived neurotrophic factor-induced motoneuron survival
7. RET-like immunostaining of spinal motoneurons in amyotrophic lateral sclerosis
8. Distinct structural elements in GDNF mediate binding to GFRα1 and activation of the GFRα1-c-Ret receptor complex
9. Motor neuron growth factors
10. Two distinct mutations of the RET receptor causing Hirschsprung's disease impair the binding of signaling effectors to a multiple docking site
11. GDNF: A potent survival factor for motoneurons present in peripheral nerve and muscle
12. Evidence of both intra- and inter-molecular cooperation for full catalytic activity of RET kinase
13. Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy
14. Oncogenic RET receptors display different autophosphorylation sites and substrate binding specificities
15. Expression of GDNF receptor (RET and GDNFR-α) mRNAs in the spinal cord of patients with amyotrophic lateral sclerosis
16. Enhanced phosphatidylinositol 3-kinase activity and high phosphorylation state of its downstream signaling molecules mediated by Ret with the MEN 2B mutation
17. Decreased phosphorylation levels of TrkB neurotrophin receptor in the spinal cords from patients with amyotrophic lateral sclerosis
18. Characterization of Ret-Shc-Grb2 complex induced by GDNF, MEN 2A, and MEN 2B mutations
19. Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase/AKT signaling pathway
20. Receptors of the glial cell line-derived neurotrophic factor family of neurotrophic factors signal through the phosphatidylinositol 3-kinase pathway in spinal cord motoneurons
21. Characterization of ret proto-oncogene mRNAs encoding two isoforms of the protein product in a human neuroblastoma cell line
22. Characterization of a multicomponent receptor for GDNF
23. Functional receptor for GDNF encoded by the c-ret proto-oncogene
24. Ret-dependent and -independent mechanisms of glial cell line-derived neurotrophic factor signaling in neuronal cells
25. Spatial and temporal expression of the ret proto-oncogene product in embryonic, infant and adult rat tissues
26. Expression of the proto-oncogene Ret, a component of the GDNF receptor complex, persists in human substantia nigra neurons in Parkinson's disease
27. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis
28. Expression of glial cell line-derived neurotrophic factor mRNA in the spinal cord and muscle in amyotrophic lateral sclerosis
29. Early BDNF, NT-3, and NT-4 signaling events